首页> 外文期刊>Advances in Experimental Medicine and Biology >Therapeutic Targeting of Death Pathways in Cancer Mechanisms for Activating Cell Death in Cancer Cells
【24h】

Therapeutic Targeting of Death Pathways in Cancer Mechanisms for Activating Cell Death in Cancer Cells

机译:靶向治疗癌症细胞死亡途径的机制,激活癌细胞的细胞死亡

获取原文
获取原文并翻译 | 示例
           

摘要

Defects in apoptosis that evolve during the course of cancer progression not only provide cancer cells with intrinsic survival advantage, but also provide inherent resistance to chemotherapeutic agents. Thus, modulation of apoptosis by targeting components of the apoptotic machinery and its regulators to restore apoptotic function is a rational approach for treating cancer. With our increasing knowledge of the mechanisms of apoptosis regulation and of how apoptosis is disabled in cancer cells, numerous novel approaches targeting apoptotic pathways can now be exploited for cancer therapy. While most of these therapies are still in preclinical development, some have shown considerable promise and progressed into the clinic. This chapter summarizes the current knowledge of the apoptotic pathways and provides a selective review on the development of drugs that target the apoptotic machinery.
机译:在癌症进展过程中发生的细胞凋亡缺陷不仅为癌细胞提供了固有的生存优势,而且还提供了对化学治疗剂的固有抗性。因此,通过靶向凋亡机制及其调控因子以恢复凋亡功能来调节细胞凋亡是治疗癌症的合理方法。随着我们对细胞凋亡调控机制以及如何在癌细胞中禁用细胞凋亡的了解不断增加,现在可以将许多靶向凋亡途径的新方法用于癌症治疗。尽管这些疗法中的大多数仍处于临床前开发阶段,但有些疗法已显示出可观的前景并已进入临床。本章总结了有关凋亡途径的最新知识,并提供了针对靶向凋亡机制的药物开发的选择性综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号